Concepedia

G. Falchook

GF

Statistics

Publications

2

Citations

60

H-Index

2

Active since

2022

Affiliations

Duke Medical Center(Current)

HealthONE

Amgen (United States)

Sarah Cannon

G. Falchook is an author at Duke Medical Center specializing in malignant tumors, malignant neoplasms, and cancer cell proliferation inhibition.

Publications per year

2022–2022

2

Publications

2

OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

G. Falchook, B.T. Li, K.A. Marrone et al. · Journal of Thoracic Oncology · 2022 · 50 citations · Full text

, , +15

SO-39 Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100

H. Prenen, M. Fakih, G. Falchook et al. · Annals of Oncology · 2022 · 10 citations

, , +17

1–2 of 2